Pfizer Inc (PFE)
27.81
+0.11
(+0.40%)
USD |
NYSE |
May 03, 16:00
27.86
+0.05
(+0.18%)
After-Hours: 20:00
Pfizer Market Cap: 157.48B for May 3, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 03, 2024 | 157.48B |
| May 02, 2024 | 156.85B |
| May 01, 2024 | 153.91B |
| April 30, 2024 | 145.07B |
| April 29, 2024 | 145.19B |
| April 26, 2024 | 143.83B |
| April 25, 2024 | 143.04B |
| April 24, 2024 | 148.75B |
| April 23, 2024 | 149.04B |
| April 22, 2024 | 148.70B |
| April 19, 2024 | 147.23B |
| April 18, 2024 | 143.77B |
| April 17, 2024 | 143.94B |
| April 16, 2024 | 145.47B |
| April 15, 2024 | 146.72B |
| April 12, 2024 | 146.43B |
| April 11, 2024 | 149.15B |
| April 10, 2024 | 149.04B |
| April 09, 2024 | 151.64B |
| April 08, 2024 | 150.51B |
| April 05, 2024 | 150.96B |
| April 04, 2024 | 150.91B |
| April 03, 2024 | 154.13B |
| April 02, 2024 | 156.00B |
| April 01, 2024 | 156.97B |
| Date | Value |
|---|---|
| March 28, 2024 | 157.14B |
| March 27, 2024 | 157.31B |
| March 26, 2024 | 156.23B |
| March 25, 2024 | 155.32B |
| March 22, 2024 | 154.93B |
| March 21, 2024 | 156.63B |
| March 20, 2024 | 156.85B |
| March 19, 2024 | 156.46B |
| March 18, 2024 | 156.97B |
| March 15, 2024 | 158.21B |
| March 14, 2024 | 159.29B |
| March 13, 2024 | 159.80B |
| March 12, 2024 | 158.61B |
| March 11, 2024 | 160.65B |
| March 08, 2024 | 154.13B |
| March 07, 2024 | 151.70B |
| March 06, 2024 | 153.96B |
| March 05, 2024 | 147.68B |
| March 04, 2024 | 146.60B |
| March 01, 2024 | 150.57B |
| February 29, 2024 | 150.40B |
| February 28, 2024 | 153.12B |
| February 27, 2024 | 151.84B |
| February 26, 2024 | 153.48B |
| February 23, 2024 | 156.75B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
143.04B
Minimum
Apr 25 2024
343.79B
Maximum
Dec 16 2021
220.95B
Average
210.07B
Median
Jan 14 2020
Market Cap Benchmarks
| Amgen Inc | 166.99B |
| Johnson & Johnson | 359.25B |
| Eli Lilly and Co | 698.52B |
| Viking Therapeutics Inc | 8.487B |
| Moderna Inc | 47.90B |
Market Cap Related Metrics
| PS Ratio | 2.865 |
| Price to Book Value | 1.769 |
| Price | 27.81 |
| Earnings Yield | -0.22% |
| Operating PE Ratio | 132.41 |
| Normalized PE Ratio | 46.45 |